Heather Cloud Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Cecilia Esposito Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Mrs. Jennifer Sue Buchinsky Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 240, Glenshaw, PA 15116 Phone: 412-406-7461 |
Kristen Gephart Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Rebecca Klawinski Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Madeline Zarger Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Natalie Ruemler Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Jennifer Arrington Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Ashley Labella Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Phoebe Pierre Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Amanda Ferguson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Alison Defurio Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Brandi Brendle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 Fax: 412-767-5960 |
Cara Markowitz Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3390 Saxonburg Blvd, Glenshaw, PA 15116 Phone: 412-767-5967 Fax: 412-767-5960 |
Claire Elizabeth Mccarthy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Erica Menhart Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Rebecca Sax Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 Fax: 412-767-5960 |
Kaitlin Krysevig Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3390 Saxonburg Blvd, Suite 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Mckenzie Banas Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3390 Saxonburg Blvd Ste 250, Glenshaw, PA 15116 Phone: 412-767-5967 |
Jessica Le Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Kimble Dr, Glenshaw, PA 15116 Phone: 412-841-3950 |
News Archive
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that the first cohort of patients has been dosed in a Phase I clinical trial of ME-344, the Company's lead mitochondrial inhibitor drug candidate, in patients with refractory solid tumors.
As the world struggles to overcome the current COVID-19 pandemic with non-pharmacological interventions, in the absence of an effective drug or vaccine, existing immunomodulators are being repurposed. A new study published on the preprint server medRxiv* in May 2020 shows no clinical benefit to the use of one such drug, called interferon beta 1b (IFN beta1b).
Combining computerized tomography with fluorodeoxyglucose positron emission tomography images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta.
› Verified 8 days ago